Clinical Study
Parameters of Blood Count and Tumor Markers in Patients with Borderline Ovarian Tumors: A Retrospective Analysis and Relation to Staging
Table 2
Tumor markers (meanstandard deviation) in serous histological subtypes () and nonserous () borderline ovarian tumors.
| | Serous Mean ± standard deviation | Nonserous Mean ± standard deviation |
| CA-125 (U/mL) | | | CA-15.3 (U/mL) | | | CA-19.9 (U/mL) | | | CEA (U/mL) | | | AFP (U/mL) | | |
|
|
Unpaired -test; not significant.
|